Status Asthmaticus Clinical Trial
Official title:
High Flow Nasal Cannula Versus Standard Oxygen Therapy in Children With Status Asthmaticus: a Randomized Controlled Trial
In France, over 2.5 million people suffer from asthma, including one-third of children. This is the chronic respiratory disease leading to the highest rate of hospitalization. The conventional oxygen delivery means in children are the non-rebreather face mask or low flow nasal cannula (standard oxygen therapy - SOT). New non-invasive ventilatory support systems such as High Flow Nasal Cannula (HFNC) are emerging. These are nasal cannulas allowing the delivery of a high air (or oxygen) flow, exceeding the inspiratory flow of patients with acute respiratory failure, allowing to deliver a slight positive expiratory pressure while ensuring humidification and warming of the airways. Aerosol administration is also possible with excellent efficiency and without interrupting respiratory assistance. Physiological data and clinical studies in other pathologies suggest the interest of this technique during the asthma attack, but no comparative study currently exists in this indication. The HFNCs could have their place upstream of Non Invasive Ventilation (NIV), thus replacing non-rebreather face mask sometimes not tolerated by the children. The investigators's hypothesis is that HFNCs could improve patients' health faster, reduce the use of other ventilatory assistance (NIV, invasive ventilation) and reduce the duration of hospitalization in intensive care units or continuous monitoring units (CMU).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02872597 -
Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
|
Phase 1 | |
| Terminated |
NCT02966184 -
Comparison of Albuterol for Status Asthmaticus
|
Phase 4 | |
| Enrolling by invitation |
NCT00750568 -
Intravenous Terbutaline in Severe Status Asthmaticus
|
N/A | |
| Completed |
NCT00124995 -
Trial of Terbutaline for the Treatment of Status Asthmaticus in Children
|
Phase 4 | |
| Recruiting |
NCT05819541 -
Treating Exacerbations of Asthma With Oral Montelukast in Children
|
Phase 2 | |
| Completed |
NCT01524198 -
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room
|
Phase 2/Phase 3 | |
| Terminated |
NCT02780479 -
Steroids in Children Hospitalized With Asthma
|
Phase 4 | |
| Withdrawn |
NCT01403428 -
Non Invasive Positive Pressure Ventilation in Status Asthmaticus
|
Phase 2 | |
| Terminated |
NCT00683449 -
Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma
|
Phase 2 | |
| Withdrawn |
NCT03219736 -
NiPPV in the Treatment of Acute Asthma Exacerbations
|
N/A | |
| Completed |
NCT00722020 -
HFCWO in Hospitalized Asthmatic Children
|
N/A | |
| Withdrawn |
NCT03338205 -
The Role of Ketamine as an Adjuvant Therapy for Children With Acute Status Asthmaticus
|
Phase 3 | |
| Completed |
NCT02302261 -
Pleth Variability and Asthma Severity in Children
|
N/A | |
| Recruiting |
NCT01770899 -
Evaluation Montelukast in the Treatment of Status Asthmaticus
|
N/A | |
| Withdrawn |
NCT01188473 -
Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus
|
Phase 1 | |
| Withdrawn |
NCT04656587 -
BPAP in Pediatric Asthma Pilot Study
|
N/A | |
| Completed |
NCT04929626 -
Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus
|
Phase 1 | |
| Completed |
NCT00623688 -
Effectiveness and Cost Study Comparing Two Ways to Deliver Albuterol for the Treatment of Asthma in the Hospital
|
N/A | |
| Recruiting |
NCT00494572 -
Montelukast With Status Asthmaticus, Ages 6-18
|
Phase 2/Phase 3 | |
| Recruiting |
NCT00491790 -
Montelukast With Status Asthmaticus, Ages 2-5
|
Phase 2/Phase 3 |